Yap TA, Vieito M, Baldini C, Sepulveda-Sanchez JM, et al. First-In-Human Phase I Study of a Next-Generation, Oral, TGFbeta Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer. Clin Cancer Res 2021;27:6666-6676.
PMID: 34548321